Helmet Non-Invasive Ventilation for COVID-19 Patients (Helmet-COVID): study protocol for a multicentre randomised controlled trial

Yaseen M Arabi, Haytham Tlayjeh, Sara Aldekhyl, Hasan M Al-Dorzi, Sheryl Ann Abdukahil, Mohammad Khulaif Al Harbi, Husain Al Haji, Mohammed Al Mutairi, Omar Al Zumai, Eman Al Qasim, Wedyan Al Wehaibi, Saad Al Qahtani, Fahad Al-Hameed, Jamal Chalabi, Mohammed Alshahrani, Talal Albrahim, Abdulrahman Alharthy, Ahmed Mady, Abdulhadi Bin Eshaq, Ali A Al Bshabshe, Zohair Al Aseri, Zainab Al Duhailib, Ayman Kharaba, Rakan Alqahtani, Adnan Al Ghamdi, Ali Altalag, Khalid Alghamdi, Mohammed Almaani, Haifa Algethamy, Ahmad Al Aqeily, Faisal Al Baseet, Hashem Al Samannoudi, Mohammed Al Obaidi, Yassin T Ismaiel, Abdulrahman A Al-Fares, Yaseen M Arabi, Haytham Tlayjeh, Sara Aldekhyl, Hasan M Al-Dorzi, Sheryl Ann Abdukahil, Mohammad Khulaif Al Harbi, Husain Al Haji, Mohammed Al Mutairi, Omar Al Zumai, Eman Al Qasim, Wedyan Al Wehaibi, Saad Al Qahtani, Fahad Al-Hameed, Jamal Chalabi, Mohammed Alshahrani, Talal Albrahim, Abdulrahman Alharthy, Ahmed Mady, Abdulhadi Bin Eshaq, Ali A Al Bshabshe, Zohair Al Aseri, Zainab Al Duhailib, Ayman Kharaba, Rakan Alqahtani, Adnan Al Ghamdi, Ali Altalag, Khalid Alghamdi, Mohammed Almaani, Haifa Algethamy, Ahmad Al Aqeily, Faisal Al Baseet, Hashem Al Samannoudi, Mohammed Al Obaidi, Yassin T Ismaiel, Abdulrahman A Al-Fares

Abstract

Introduction: Non-invasive ventilation (NIV) delivered by helmet has been used for respiratory support of patients with acute hypoxaemic respiratory failure due to COVID-19 pneumonia. The aim of this study was to compare helmet NIV with usual care versus usual care alone to reduce mortality.

Methods and analysis: This is a multicentre, pragmatic, parallel randomised controlled trial that compares helmet NIV with usual care to usual care alone in a 1:1 ratio. A total of 320 patients will be enrolled in this study. The primary outcome is 28-day all-cause mortality. The primary outcome will be compared between the two study groups in the intention-to-treat and per-protocol cohorts. An interim analysis will be conducted for both safety and effectiveness.

Ethics and dissemination: Approvals are obtained from the institutional review boards of each participating institution. Our findings will be published in peer-reviewed journals and presented at relevant conferences and meetings.

Trial registration number: NCT04477668.

Keywords: COVID-19; adult intensive & critical care; respiratory medicine (see thoracic medicine).

Conflict of interest statement

Competing interests: None declared.

© Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

References

    1. World Health Organization. Available: [Accessed 17 Aug 2021].
    1. Marini JJ, Gattinoni L. Management of COVID-19 respiratory distress. JAMA 2020;323:2329. 10.1001/jama.2020.6825
    1. Guan W-J, Ni Z-Y, Hu Y, W-j G, Z-y N, et al. . Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med 2020;382:1708–20. 10.1056/NEJMoa2002032
    1. Ñamendys-Silva SA. Respiratory support for patients with COVID-19 infection. Lancet Respir Med 2020;8:e18. 10.1016/S2213-2600(20)30110-7
    1. Richardson S, Hirsch JS, Narasimhan M, et al. . Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the new York City area. JAMA 2020;323:2052. 10.1001/jama.2020.6775
    1. Xu X-P, Zhang X-C, Hu S-L. Noninvasive ventilation in acute hypoxemic Nonhypercapnic respiratory failure. Crit Care Med 2017;45. 10.1097/CCM.0000000000002361
    1. Brambilla AM, Aliberti S, Prina E, et al. . Helmet CPAP vs. oxygen therapy in severe hypoxemic respiratory failure due to pneumonia. Intensive Care Med 2014;40:942–9. 10.1007/s00134-014-3325-5
    1. Arulkumaran N, Brealey D, Howell D, et al. . Use of non-invasive ventilation for patients with COVID-19: a cause for concern? Lancet Respir Med 2020;8:e45. 10.1016/S2213-2600(20)30181-8
    1. Esquinas Rodriguez AM, Papadakos PJ, Carron M, et al. . Clinical review: helmet and non-invasive mechanical ventilation in critically ill patients. Crit Care 2013;17:cc1187510.1186/cc11875
    1. Patroniti N, Foti G, Manfio A, et al. . Head helmet versus face mask for non-invasive continuous positive airway pressure: a physiological study. Intensive Care Med 2003;29:1680–7. 10.1007/s00134-003-1931-8
    1. Cosentini R, Brambilla AM, Aliberti S, et al. . Helmet continuous positive airway pressure vs oxygen therapy to improve oxygenation in community-acquired pneumonia: a randomized, controlled trial. Chest 2010;138:114–20. 10.1378/chest.09-2290
    1. Patel BK, Wolfe KS, Pohlman AS, et al. . Effect of noninvasive ventilation delivered by helmet vs face mask on the rate of endotracheal intubation in patients with acute respiratory distress syndrome: a randomized clinical trial. JAMA 2016;315:2435. 10.1001/jama.2016.6338
    1. Foti G, Sangalli F, Berra L, et al. . Is helmet CPAP first line pre-hospital treatment of presumed severe acute pulmonary edema? Intensive Care Med 2009;35:656–62. 10.1007/s00134-008-1354-7
    1. Squadrone V, Coha M, Cerutti E, et al. . Continuous positive airway pressure for treatment of postoperative hypoxemia: a randomized controlled trial. JAMA 2005;293:589. 10.1001/jama.293.5.589
    1. Patel BK, Wolfe KS, MacKenzie EL, et al. . One-Year outcomes in patients with acute respiratory distress syndrome enrolled in a randomized clinical trial of helmet versus facemask noninvasive ventilation. Crit Care Med 2018;46:1078–84. 10.1097/CCM.0000000000003124
    1. Liu Q, Gao Y, Chen R, et al. . Noninvasive ventilation with helmet versus control strategy in patients with acute respiratory failure: a systematic review and meta-analysis of controlled studies. Crit Care 2016;20:265. 10.1186/s13054-016-1449-4
    1. Luo Y, Luo Y, Li Y. Helmet CPAP versus oxygen therapy in hypoxemic acute respiratory failure: a meta-analysis of randomized controlled trials, 2016.
    1. Ferreyro BL, Angriman F, Munshi L, et al. . Association of noninvasive oxygenation strategies with all-cause mortality in adults with acute hypoxemic respiratory failure: a systematic review and meta-analysis. JAMA 2020;324:57–67. 10.1001/jama.2020.9524
    1. Kyeremanteng K, Gagnon L-P, Robidoux R, et al. . Cost analysis of noninvasive helmet ventilation compared with use of noninvasive face mask in ARDS. Can Respir J 2018;2018:6518572:1–5. 10.1155/2018/6518572
    1. Grieco DL, Menga LS, Cesarano M, et al. . Effect of helmet noninvasive ventilation vs high-flow nasal oxygen on days free of respiratory support in patients with COVID-19 and moderate to severe hypoxemic respiratory failure: the HENIVOT randomized clinical trial. JAMA 2021;325:1731. 10.1001/jama.2021.4682
    1. Bellani G, Laffey JG, Pham T, et al. . Epidemiology, patterns of care, and mortality for patients with acute respiratory distress syndrome in intensive care units in 50 countries. JAMA 2016;315:788. 10.1001/jama.2016.0291
    1. Hasan SS, Capstick T, Ahmed R, et al. . Mortality in COVID-19 patients with acute respiratory distress syndrome and corticosteroids use: a systematic review and meta-analysis. Expert Rev Respir Med 2020;14:1149–63. 10.1080/17476348.2020.1804365
    1. Centers for Disease Control and Prevention . Coronavirus disease 2019 (COVID-19). 2020 interim case definition, Approved April 5, 2020. Available: [Accessed 02 Jun 2020].
    1. Arabi YM, Al Aseri Z, Alaama T, et al. . National approach to standardize and improve mechanical ventilation. Ann Thorac Med 2019;14:101. 10.4103/atm.ATM_63_19
    1. Alhazzani W, Al-Suwaidan F, Al Aseri Z, et al. . The Saudi critical care Society clinical practice guidelines on the management of COVID-19 patients in the intensive care unit. Saudi Crit Care J 2020;4:27–44. 10.4103/sccj.sccj_15_20
    1. Alhazzani W, Evans L, Alshamsi F, et al. . Surviving sepsis campaign guidelines on the management of adults with coronavirus disease 2019 (COVID-19) in the ICU: first update. Crit Care Med 2021;49:e219–34. 10.1097/CCM.0000000000004899
    1. Alhazzani W, Møller MH, Arabi YM, et al. . Surviving sepsis campaign: guidelines on the management of critically ill adults with coronavirus disease 2019 (COVID-19). Crit Care Med 2020;48:e440–69. 10.1097/CCM.0000000000004363
    1. Coronavirus disease (COVID-19) technical guidance: patient management. Available: [Accessed 1 Mar 2021].
    1. Knaus WA, Draper EA, Wagner DP, et al. . Apache II: a severity of disease classification system. Crit Care Med 1985;13:818–29.
    1. Cook D, Lauzier F, Rocha MG, et al. . Serious adverse events in academic critical care research. CMAJ 2008;178:1181–4. 10.1503/cmaj.071366

Source: PubMed

Sponsors et collaborateurs

Les conditions médicales

Interventions en matière de drogue

3
S'abonner